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The  present  paper  reviews  the  roles  of endothelin  (ET)  in the  rat  submandibular  gland  (SMG).  ET and  its
mRNA  are  expressed  in the  granular  convoluted  tubule  (GCT)  segment  by  immunostaining  and  in situ
hybridization,  respectively.  ET is  synthesized  in  granular  cells of  the  GCT  segment,  stored  in  secretory




SMG  in  mice  and  rats  express  many  kinds  of growth  factor such  as  epidermal  growth  factor  and  nerve
growth  factor.  These  growth  factors  are  discharged  into  saliva  and  thought  to  regulate  oral-esophageal
and  gastrointestinal  mucosa.  ET  acts  as  a potent  vasoconstrictor  with  mitogenic  property  and  is  excreted
from  Weibel-Palade  bodies  in  vascular  endothelial  cells.  ET  in  the  salivary  origin  may  regulate  its  own
functions  as  noted  in the  endothelial  origin.  This  review  deals  with  comparative  discussion  of  ET  and
other  growth  factors,  which  originate  from  GCT  segments  in  rodents.© 2011 Japanese Stomatological Society. Published by Elsevier Ltd. All rights reserved.
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. Introduction
Saliva contains digestive enzymes, mucin, antibacterial pep-
ides, and growth factors/cytokines. Submandibular salivary gland
onsists of acini and the ductal system including the intercalated
uct, the granular convoluted tubule (GCT), the striated duct, and
he excretory duct. Since the discovery of nerve growth factor (NGF)
nd epidermal growth factor (EGF) in the murine submandibular
land (SMG) [1–3], considerable advances have been highlighted
insulin-like growth factor (IGF), vascular endothelial growth factor
(VEGF), as well as arterial natriuretic peptides (ANP). The GCT seg-
ment contains granular, pillar, and transitional cells. Among these
cells, granular cells are characterized by the existence of secretory
granules containing several growth factors. Pillar cells contain S-
100 protein, which acts as calcium intercellular signaling protein
involved in the discharge of granules in the GCT [5]. Salivary duct
cells in humans express high levels of human EGF (hEGF), and it is
suggested that hEGF may  be secreted into saliva from the striated
duct cells [8,9]. Human saliva contains defensin, histatin, and othern the functional and biophysiological roles of the two  growth
actors as well as other growth factors. Recent reports regarding
alivary growth factors have dealt with other growth factors [4–7];
ransforming growth factor (TGF), ﬁbroblast growth factor (FGF),
∗ Corresponding author. Tel.: +81 58 329 1472; fax: +81 58 329 1472.
E-mail  address: shin@dent.asahi-u.ac.jp (S. Sumitomo).
348-8643/$ – see front matter ©  2011 Japanese Stomatological Society. Published by Els
oi:10.1016/S1348-8643(11)00005-Xantimicrobial peptides, suggesting they are involved in homeosta-
sis as well as maintenance of the oral health condition [10].
Endothelin (ET) is a potent vasoconstrictor with mitogenic prop-
erties, and ET is stored in Weibel-Palade (WP) bodies and secreted
to circulating blood. Thus, ET showed one endocrine function in the
endothelial cells. ET has recently been discovered in the rat GCT seg-
ment, which is expressed in granular cells by in situ hybridization
and released into saliva, with autocrine and exocrine roles. The
evier Ltd. All rights reserved.























































Fig. 1. Immunohistochemical staining for endothelin (ET)-1 (A) and ET-3 (B) andM.  Mori et al. / Oral Scien
resent paper deals with the ET expression in rat SMG, as well as
ther growth factors from the GCT segments.
. Structure and biophysiology of ET
ET is classiﬁed into 3 isopeptides: ET-1, ET-2, and ET-3 with
hree corresponding chromosomal loci [11], and these peptides are
.5 kDa and composed of 21 amino acids.
.1.  ET converting enzyme
ET  converting enzyme (ECE) and ET receptors have been iden-
iﬁed and investigated for their biosynthesis and gene expression
12–15]. ET is produced from a 39 amino acid precursor, big ET,
hrough the action of ECE [16]. The bigETs undergo ﬁnal conver-
ion to the active form of the peptide by ECE. The two  major ECE
soforms are ECE-1 and ECE-2, which are membrane-bound zinc
etalloproteases that show 59% amino acid sequence homology
nd cleave bigET-1 with much greater efﬁciency than either bigET-
 or bigET-3 [17]. ECE is localized in the cardiac endothelial cells,
espiratory tissue, and brain. ECE-1a processed big ET-1 to ET-1 by
roteolytic activity in vitro [18]. ECE exists in isoforms localized
n endothelial cells and involves the local production of ET. ECE-
 is a metalloproteinase and cleaves bigET-1 to generate mature
T-1 in the trans-Golgi apparatus [19]. Elevated plasma ET-1 levels
ay  be involved in the pathogenesis of cardiovascular disease, and
he ET degradation enzyme may  play a role in the homeostasis of
irculating ET-1 and vascular tone [20].
.2. ET receptors
ET  receptors are grouped into ETA receptor and ETB receptor.
hese receptors exist in the blood vessel and non-vessel tissues.
he rat ETA receptor mRNA is markedly expressed in vasucular
uscle cells. ETB receptor mRNA is not signiﬁcantly expressed
n vascular smooth muscle cells, whereas ETB receptor mRNA
s widely distributed in many cells and tissues [21]. ET-1, ET-
, and ET-3 bind to ETA receptor with similar afﬁnity and both
TA receptor and ETB receptor belong to the G-protein-coupled
eceptor superfamily. ET-1 and sarafotoxin, a group of 21-residue
ardiotoxic peptides from snake venom, have a stronger afﬁn-
ty for ETA receptor than ET-2 and ET-3 [22]. The soluble ETA
eceptors or antibodies against ETA receptor can selectively block
T-1-induced pressure in hamster atherosclerosis, and ET promotes
he early inﬂammatory phase of atherosclerosis [23]. Immuno-
istochemical studies on ET and ET receptor, suggested that the
xpression of ET-1 and ETA receptor are involved in the pathology
f the atherosclerotic lesions of apolipoprotein E-deﬁcient mice
24]. These two endothelin receptor subtypes, ETA and ETB, have
pposing actions on ET. The function of ETA receptor is to promote
asoconstriction, growth, and inﬂammation while ETB receptor
roduces vasodilation, increase in sodium excretion, and inhibits
rowth and inﬂammation [25]. In human athelosclerotic lesions,
ncreased expression of ETB receptor in vascular smooth muscle
ells could explain increased vasoconstrictor effects of sarafotoxin
n the human forearm vasculature [26]. These two  receptors are
lassiﬁed on the basis of rank order of potencies for the ETs, being
T1 = ET2  ET3 for the ETA receptor and ET1 = ET2 = ET3 for the ETB
eceptor [27].
.3.  Function and distribution of ETET is reported to be biosynthesized and stored in WP  bod-
es in the endothelial cells of umbilical vein by immunoelectron
icroscopy, and ET may  be secreted by exocytosis into the blood-
tream. ET is also produced from the Golgi apparatus [28]. WPin situ hybridization of ET-3 (C) in the mouse submandibular gland. ET-1 stains
strongly  in the pillar cells (A) which are located between granular cells and ET-3
diffusely  in the granular cells (B). ET-3 mRNA is expressed speciﬁcally in secretory
granules  of GCT segment (C), indicating the biosynthesis of ET-3 in this site.
bodies of the endothelial cells are involved in extracellular release
of ET-1 in the regulated pathway [29]. In the rat liver tissues, ET-1 is
secreted by exocytosis of WP  bodies in the vascular cells, and both
ETA and ETB receptors are activated in the sinusoidal membrane and
also interhepatocellular processes, suggesting that hepatic vascular
circulation is involved in the receptor-mediated paracrine system
in the normal liver and in dysfunctional liver diseases [30]. The
rat carotid body also produces ET. In immunoelectron microscopy,
gold particles of ET-1 and calcitonin gene-related peptide (CGRP)
are expressed in rough endoplasmic reticulum (ER) and in the WP
bodies, and coexpression of ET-1 and CGRP is found in the WP bod-
ies [31]. ET may  be a marker for arteriovascular disease and whether
it participates in atherogenic processes or is merely released from
M.  Mori et al. / Oral Science International 8 (2011) 7– 10 9
Fig. 2. Biosynthesis of endothelin in rat submandibular gland, and pathway of endothelin secretion into saliva and enter oral cavity and digestive tract and ﬁnally circulation
of endothelin into blood stream. Granular convoluted tubule segment is composed of granular cells and pillar cells. Granular cell includes endothelin as well as many
growth factors (epidermal growth factor, nerve growth factor, arterial natriuretic peptide, and so on). Pillar cell locates between granular cells and is strongly positive to
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s100  protein. Striated duct cell is characterized by existence of basal striation (ba
triated duct shows strong succinate dehydrogenase (SDH) activity (mitochondrial e
pithelium composed of two or more layer of cells. Basal cells are generally positive
amaged endothelial cells [32]. It is also reported that ETs are syn-
hesized in vascular smooth muscle cells in culture and its levels
re within the biologically effective concentration of ET [33].
In  the central nervous system the key roles of ETs, ANP, and
ngiotensin are identiﬁed as vasocontractive peptides. Those pep-
ides are candidates for neurotransmitters in the central nervous
ystem, neuron modulators, and circulating hormones via the
ypothalamus–pituitary axis [34]. Biosynthesis of ET in normal ker-
tinocytes has been reported in cultured cells [32], and human
ingival keratinocytes in periodontitis express ET in biochemical
nalysis in culture [35]. Psoriasis is very effectively treated by ABT-
27, which is an ET antagonist, because ABT-627 can inhibit the
roliferation of keratinocytes from psoriasis patients [36]. It has
een reported that ABT-627, also inhibits tumor growth in cervi-
al squamous cell carcinoma by blocking or inhibiting ETA receptor
n vivo [37]. Gingival keratinocytes in periodontitis and oral car-
inoma cells may  also express ET, and topical application of ET
ntagonists may  become new therapeutic modalities for the lesions
f oral mucosa.
.  ET in salivary glands
The  existence of ET in the salivary gland is not well known,
owever a study has shown that ET is expressed in the rat sali-
ary gland. Lam et al. [38] noted that human saliva contains ET
y radioimmunoassay 2.0+/0.2 pmol/1iter (n = 15) and reveals 6
eaks [ET-1, -2, -3 and big ET (n = 4)], and rat parotid salivary gland
lso shows ET. Katsura et al. [39] indicated that the expression
f ET-1 and ET-3, ETA and ETB receptors, and mRNA of ET-3 is
xpressed in granular cells of GCT segment of the rat submandibu-
ar glands. Namba [40] reported that, in postnatal rats, GCT in SMG
re found ﬁrstly at 8 weeks and matured at 14 weeks, accompa-
ying the increased staining in granular cells. Testosterone-treated
at showed increased size and more abundant secretary granules in
CT segments compared to normal rat. ET immunoreactivity andn situ hybridization of ET-3 is also conﬁned abundantly to gran-
lar cells of GCT segment in the SMG  of testosterone-treated rat.
T concentration in plasma, SMG  homogenate and -stimulated
aliva was measured by radioimmunoassay. ET concentration inmbrane infolding) and mitochondria are present between basal infolding so that
e). Ductal basal cells in striated duct are rarely found. Collecting (or excretory) duct
onoclonal antibody keratin (PKK1 K812) staining.
SMG and saliva are dependent upon the growth level of GCT cells.
From immunohistochemical study of ET in the GCT segment of
the rat SMG, it is interesting to note that ET-1 is limited to pillar
cells (Fig. 1A), whereas ET-3 is localized in granular cells. The GCT
segment of rat SMG  composed of two  different cells, one is pillar
cell showing S-100 positive and second is granular cell containing
many growth factors, such as EGF, and NGF and also ET-3 and ET-3
mRNA (Fig. 1B and C). ET-3 is produced in granular cells and dis-
charged into saliva. Following methoxamine injection of the rat,
immunostaining of both ET-1 and ET-3 decreases in granular cells
of GCT segments and is observed to be only trace-amounts or nega-
tive. Paracrine or autocrine mechanism involving ETs secretions are
obscure in the salivary glands. It has been reported that ET-1, but
not ET-3 potentiated both cholinergic- and adrenergic-evoked sali-
vation through ETA receptor. ETA and ETB receptor mRNAs as well
as ETs were demonstrated in the rat SMG  by reverse transcriptase-
polymerase chain reaction method. Immunohistochemical staining
of ETA receptor was localized around the interlobular ducts and
acini, whereas ETB receptor staining was  restricted to small blood
vessels. ETs are involved in the brain regulation of cholinergic and
adrenergic saliva secretion through the activation of distinct brain
ET receptors and parasympathetic pathways [41].
4.  Wound healing, growth factors of salivary gland origin
and  ET
Exocrine ETs secreted into the oral cavity from the SMG  are
transported to the esophagus, stomach, and small intestine, and
ﬁnally enter the bloodstream (Fig. 2). In this system, it has been
well recognized that salivary EGF in the mouse and rat inﬂuenced
biological actions in tissue repair and regeneration in wounds of
the oral-esophageal mucosa as well as gastrointestinal tract [42].
Wound healing of the skin was enhanced by licking, and was
thought to occur by the deposit of salivary EGF to the wound sur-
face. Other growth factors to promote wound healing include local
production of NGF, TGF-/, IGF, FGF, and bone morphogenetic
protein of salivary origin [6]. The duct cells of the SMG  and parotid
gland of mice and rats synthesize both IGF-I and IGF-II [43] and as





































































[46] Tétrault MP,  Chailler P, Rivard N, et al. Differential growth factor induc-
tion and modulation of human gastric epithelial regeneration. Exp Cell Res0 M.  Mori et al. / Oral Scien
actors in the systemic wound healing process are related to dia-
etes onset [45]. In a study to discriminate individual actions of
peciﬁc growth factors: EGF, TGF-, TGF1, IGF-I, IGF-II, and hep-
tocytic growth factor (HGF), in the human gastric epithelial cell
ine [46], it was shown that growth factors differentially regulate
he regeneration of human gastric epithelial cells through speciﬁc
odulation of cell shape adaptation, migration, and proliferation,
urther stressing that a coordination of growth factor activities
ould be necessary for the normal progression of post-wounding
pithelial repair.
Ulcer,  mucositis, and chronic wounds result in tissue necro-
is, if mucosal ischemia, free radical formation, and micro-vascular
njury occur. Healing mechanisms of ulcer or wounds are complex
rocesses, which involve cell migration, proliferation, angiogen-
sis, re-epithelialization, matrix formation, and all the processes
nvolving growth factors and cytokines. In the mucosal surface of
he upper digestive tract, many growth factors with salivary origin
ay have important roles in promoting the healing; in particular,
Ts may  be important, because of their activities for angiogenesis
nd cell proliferation.
Tarnawski [47] stated that cellular and molecular mechanisms
f gastrointestinal ulcer healing and related events are controlled
y growth factors: EGF, HGF, TGF-, VEGF, keratinocyte growth
actor, platelet derived growth factor, angiopoietins and transcrip-
ion factor activated by tissue injury in a spatially and temporally
oordinating manner. He also noted that VEGF, angiopoietins, nitric
xide, ET, and metalloproteinases are important for morphogene-
is, vascular remodeling, and mucosal regeneration. The present
ini-review suggests that ETs, which are secreted from granular
ells of GCT segment in the SMG, enhance angiogenesis and pro-
ote the wound healing in the oral mucosa as well as digestive
ract.
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